Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Neuroendovascular Coil Market Growth From $1.49 Billion In 2026 To $1.96 Billion By 2030 At A CAGR Of 7%
The neuroendovascular coil market size has demonstrated robust expansion over recent years. This market is expected to increase from $1.39 billion in 2025 to $1.49 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.1%. Key factors contributing to its historical growth include a rising incidence of cerebral aneurysms, ongoing advancements in endovascular treatment techniques, an upsurge in neurointerventional procedures, the proliferation of stroke treatment centers, and enhanced clinician proficiency in neurovascular care.
The neuroendovascular coil market is anticipated to show considerable expansion in the coming years. Its valuation is predicted to reach $1.96 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.0%. This projected growth throughout the forecast period can be attributed to the increasing adoption of next-generation embolization devices, a rise in investments towards neurovascular research, the broadening availability of minimally invasive treatment options, a growing demand for safer aneurysm management, and an increasing focus on personalized neurointerventional care. Key trends for the forecast period include the increasing uptake of advanced detachable coil designs, a rising utilization of flow-diverter and matrix coils, a growing preference for minimally invasive neurovascular procedures, the expansion of high-precision coil deployment techniques, and an enhanced emphasis on long-term treatment outcomes.
Get A Free Sample Report With In-Depth Market Insights:
Neuroendovascular Coil Market Industry Drivers: What’s Behind The Revenue Growth?
The increasing incidence of neurovascular diseases is projected to stimulate expansion in the Neuroendovascular Coil Market moving forward. Neurovascular diseases are conditions that impact the blood vessels supplying the nervous system, frequently leading to neurological symptoms and complications. The rise in these diseases is attributed to an aging global population, as older individuals are more susceptible to conditions such as strokes and aneurysms, thereby escalating the overall disease burden. Neuroendovascular coils are utilized to treat neurovascular diseases by being inserted into blood vessels to either block off or stabilize abnormal blood vessel structures, thereby mitigating the risk of hemorrhage or other complications. For instance, a report published by the Stroke Association, a UK-based stroke support charity, in March 2025, indicated that in 2024, the UK had 1.3 million stroke survivors, a figure anticipated to climb to 2.1 million by 2035. Consequently, the growing prevalence of neurovascular diseases is a significant driver for the Neuroendovascular Coil Market’s growth.
Neuroendovascular Coil Market Driver: Surge In Healthcare Expenditure Fuels Neuroendovascular Coil Market Growth
Neuroendovascular Coil Market Segment Analysis And Revenue Potential
The neuroendovascular coil market covered in this report is segmented –
1) By Product Type: Guglielmi Detachable Coils (GDCs), Matrix Coils
2) By Indication: Ruptured Aneurysm, Unruptured Aneurysm
3) By Application: Medical Teaching, Cerebral Aneurysm Treatment, Other Vascular Abnormalities
4) By End User: Hospitals, Ambulatory Surgical Centers (ASCs), Stroke Centers, Other End Users
Subsegments:
1) By Guglielmi Detachable Coils (GDCs): Soft GDCs, Standard GDCs, Detachable GDCs With Various Configurations
2) By Matrix Coils: Soft Matrix Coils, Coated Matrix Coils, Detachable Matrix Coils, Flow Diverter Matrix Coils
#Neuroendovascular Coil Market Growth Trends: What’s Shaping The Future Outlook?
Leading companies in the neuroendovascular coil market are prioritizing technological advancements, particularly in developing shape-configured, adaptive embolization coils. These innovations facilitate accurate vessel wall contact, regulated placement, and comprehensive blockage within intricate and diminutive neurovascular formations. Such adaptive embolization coils utilize unique coil shapes and anchoring mechanisms to align with vessel anatomy, enhance occlusion effectiveness, and permit subsequent filling with supplementary coils, thereby boosting the precision and steadiness of procedures for intracranial aneurysms and other neurovascular conditions. A notable example is Penumbra, a US-based neurovascular medical device company, which introduced its SwiftSET Neuro Embolization Coil in October 2025. This coil boasts a .135 primary diameter, a shape-optimized design for vessel wall apposition, and an anchoring structure that enables medical professionals to establish an initial anchor and then populate the space with SwiftPAC coils, ensuring precise, manageable, and stable embolization, even in constricted or winding vessels.
Neuroendovascular Coil Market Company Landscape And Competitive Strategy
Major companies operating in the neuroendovascular coil market are Johnson & Johnson Services Inc., Medtronic PLC, Stryker Corporation, Boston Scientific Corporation, Terumo Corporation, Kaneka Neurovascular USA, W.L. Gore & Associates Inc., Merit Medical Systems Inc., MicroPort Scientific Corporation, Penumbra Inc., MicroVention Inc., Medikit Co. Ltd., Balt USA LLC, Acandis GmbH, Rapid Medical Ltd., Shape Memory Medical Inc., Wuhan HNC Technology Co. Ltd., Intratech Medical Inc., Phenox GmbH, Cerenovus, Svelte Medical Systems
View The Full Neuroendovascular Coil Market Report:
Neuroendovascular Coil Market Largest Region: Which Geography Holds The Biggest Share?
North America was the largest region in the neuroendovascular coil market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neuroendovascular coil market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
